Our Deals
Deals
PHT acquired by ERT and Genstar Capital May 11, 2015
Overview
ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, announced that it has completed the acquisition of Boston-based PHT Corporation (PHT), the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research.
Significance
The acquisition further positions ERT as the leader in eClinical Outcome Assessments (eCOA) and patient-centric data collection, bolstering ERT’s innovative clinical trial and healthcare technologies, consulting and service offerings with PHT’s flexible eCOA system, premier eCOA scientists and world-class customer service.
The combined company will have an increased global footprint throughout North America, Europe and Asia, supporting all phases of clinical research across a broad range of therapeutic areas for small and mid-sized biopharma to CROs and large pharmaceutical companies – including the top 30 pharmaceutical companies in the world.
Crosstree’s Role
Crosstree Capital Partners served as PHT’s exclusive financial advisor.